BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26467451)

  • 1. Transcutaneous Supraorbital Nerve Stimulation (t-SNS) with the Cefaly
    Riederer F; Penning S; Schoenen J
    Pain Ther; 2015 Oct; 4(2):135-47. PubMed ID: 26467451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurostimulation of the supraorbital nerve with the Cefaly device - a new method for the treatment of migraine].
    Tabeeva GR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(3):133-140. PubMed ID: 31089108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study.
    Vikelis M; Dermitzakis EV; Spingos KC; Vasiliadis GG; Vlachos GS; Kararizou E
    BMC Neurol; 2017 May; 17(1):97. PubMed ID: 28521762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and patients' satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population.
    Magis D; Sava S; d'Elia TS; Baschi R; Schoenen J
    J Headache Pain; 2013 Dec; 14(1):95. PubMed ID: 24289825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial.
    Schoenen J; Vandersmissen B; Jeangette S; Herroelen L; Vandenheede M; Gérard P; Magis D
    Neurology; 2013 Feb; 80(8):697-704. PubMed ID: 23390177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and preventive effects of a supraorbital transcutaneous stimulator in Japanese migraine patients.
    Danno D; Iigaya M; Imai N; Igarashi H; Takeshima T
    Sci Rep; 2019 Jul; 9(1):9900. PubMed ID: 31289281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial.
    Di Fiore P; Bussone G; Galli A; Didier H; Peccarisi C; D'Amico D; Frediani F
    Neurol Sci; 2017 May; 38(Suppl 1):201-206. PubMed ID: 28527053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for electrical parameter determination in external trigeminal nerve stimulation (eTNS) for migraine: A narrative review.
    Lauritsen CG; Silberstein SD
    Cephalalgia; 2019 May; 39(6):750-760. PubMed ID: 30139273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive transcutaneous Supraorbital Neurostimulation (tSNS) using Cefaly
    Przeklasa-Muszyńska A; Skrzypiec K; Kocot-Kępska M; Dobrogowski J; Wiatr M; Mika J
    Neurol Neurochir Pol; 2017; 51(2):127-134. PubMed ID: 28159327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External trigeminal neurostimulation in patients with chronic migraine.
    Trimboli M; Marsico O; Troisi L; Fasano F
    Pain Manag; 2023 Mar; 13(3):185-192. PubMed ID: 37010047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External Trigeminal Nerve Stimulation for the Acute Treatment of Migraine: Open-Label Trial on Safety and Efficacy.
    Chou DE; Gross GJ; Casadei CH; Yugrakh MS
    Neuromodulation; 2017 Oct; 20(7):678-683. PubMed ID: 28580703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External Concurrent Occipital and Trigeminal Neurostimulation Relieves Migraine Headache: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial.
    Daniel O; Tepper SJ; Deutsch L; Sharon R
    Pain Ther; 2022 Sep; 11(3):907-922. PubMed ID: 35661128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral metabolism before and after external trigeminal nerve stimulation in episodic migraine.
    Magis D; D'Ostilio K; Thibaut A; De Pasqua V; Gerard P; Hustinx R; Laureys S; Schoenen J
    Cephalalgia; 2017 Aug; 37(9):881-891. PubMed ID: 27342225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial.
    Chou DE; Shnayderman Yugrakh M; Winegarner D; Rowe V; Kuruvilla D; Schoenen J
    Cephalalgia; 2019 Jan; 39(1):3-14. PubMed ID: 30449151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral Neuromodulation for the Management of Headache.
    Urits I; Schwartz R; Smoots D; Koop L; Veeravelli S; Orhurhu V; Cornett EM; Manchikanti L; Kaye AD; Imani F; Varrassi G; Viswanath O
    Anesth Pain Med; 2020 Dec; 10(6):e110515. PubMed ID: 34150578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migraine treatment with external concurrent occipital and trigeminal neurostimulation-A randomized controlled trial.
    Tepper SJ; Grosberg B; Daniel O; Kuruvilla DE; Vainstein G; Deutsch L; Sharon R
    Headache; 2022 Sep; 62(8):989-1001. PubMed ID: 35748757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcutaneous supraorbital neurostimulation in "de novo" patients with migraine without aura: the first Italian experience.
    Russo A; Tessitore A; Conte F; Marcuccio L; Giordano A; Tedeschi G
    J Headache Pain; 2015; 16():69. PubMed ID: 26197977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External trigeminal nerve stimulation: Potential rescue treatment for acute vestibular migraine.
    Beh SC
    J Neurol Sci; 2020 Jan; 408():116550. PubMed ID: 31677559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of external trigeminal nerve stimulation (eTNS) on laser evoked cortical potentials (LEP): A pilot study in migraine patients and controls.
    Vecchio E; Gentile E; Franco G; Ricci K; de Tommaso M
    Cephalalgia; 2018 Jun; 38(7):1245-1256. PubMed ID: 28856913
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.